These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3193211)

  • 1. Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathione.
    Ballinger JR; Reid RH; Gulenchyn KY
    J Nucl Med; 1988 Dec; 29(12):1998-2000. PubMed ID: 3193211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione.
    Neirinckx RD; Burke JF; Harrison RC; Forster AM; Andersen AR; Lassen NA
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S4-12. PubMed ID: 3192641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of technetium-99m d,1-HM-PAO decomposition in aqueous media.
    Hung JC; Corlija M; Volkert WA; Holmes RA
    J Nucl Med; 1988 Sep; 29(9):1568-76. PubMed ID: 3411374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the purity of d,l HM-PAO from diastereomeric mixtures using NMR techniques.
    Feinstein-Jaffe I; Boazi M; Tor Y
    J Nucl Med; 1989 Jan; 30(1):106-9. PubMed ID: 2911037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the arterial input curve for [99mTc]-d,l-HM-PAO by rapid octanol extraction.
    Andersen AR; Friberg H; Lassen NA; Kristensen K; Neirinckx RD
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S23-30. PubMed ID: 3192639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of technetium-99m-HM-PAO with glutathione.
    Láng JJ
    J Nucl Med; 1990 Jun; 31(6):1115-6. PubMed ID: 2393422
    [No Abstract]   [Full Text] [Related]  

  • 7. Retention of [99mTc]-d,l-HM-PAO in rat brain: an autoradiographic study.
    Hoffman TJ; Corlija M; Chaplin SB; Volkert WA; Holmes RA
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S38-43. PubMed ID: 3192640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO.
    Sasaki T; Senda M
    J Nucl Med; 1999 Jun; 40(6):1056-60. PubMed ID: 10452324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-d,l-HM-PAO, the development of a new class of 99mTc-labeled tracers: an overview.
    Lassen NA; Blasberg RG
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S1-3. PubMed ID: 3192637
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis of hexamethyl propylamine oxime and comparative study of its diastereoisomers].
    Tan T; Wang D; Kuang A; He L; Xu P
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Mar; 22(1):58-61. PubMed ID: 1774039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NMR identification and stereoisomeric purity determination of HM-PAO diastereoisomers].
    Wen JQ; Wang JZ; Shao LR
    Yao Xue Xue Bao; 1989; 24(10):733-6. PubMed ID: 2618663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiochemical purity of [99mTc]HM-PAO.
    Ballinger JR; Reid RH; Gulenchyn KY
    J Nucl Med; 1988 Apr; 29(4):572-3. PubMed ID: 3258369
    [No Abstract]   [Full Text] [Related]  

  • 13. Glutathione-mediated metabolism of technetium-99m SNS/S mixed ligand complexes: a proposed mechanism of brain retention.
    Nock BA; Maina T; Yannoukakos D; Pirmettis IC; Papadopoulos MS; Chiotellis E
    J Med Chem; 1999 Mar; 42(6):1066-75. PubMed ID: 10090789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-meso-HMPAO as a potential agent to image cerebral glutathione content.
    Sasaki T; Senda M
    J Nucl Med; 1997 Jul; 38(7):1125-9. PubMed ID: 9225804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial cerebral HM-PAO distribution compared to LCBF: use of a model which considers cerebral HM-PAO trapping kinetics.
    Lear JL
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S31-7. PubMed ID: 3263979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative local cerebral blood flow measurements with technetium-99m HM-PAO: evaluation using multiple radionuclide digital quantitative autoradiography.
    Lear JL
    J Nucl Med; 1988 Aug; 29(8):1387-92. PubMed ID: 2841432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m HM-PAO images (planar and SPECT) of the human brain.
    Abdel-Dayem HM; Sadek SA; el Sayed M; Higazi E
    Clin Nucl Med; 1988 Feb; 13(2):139-43. PubMed ID: 3280208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of technetium-99m-d,1-HMPAO to radiolysis in aqueous solutions.
    Tubergen K; Corlija M; Volkert WA; Holmes RA
    J Nucl Med; 1991 Jan; 32(1):111-5. PubMed ID: 1988613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization.
    Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M
    J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.
    Lassen NA; Andersen AR; Friberg L; Paulson OB
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S13-22. PubMed ID: 3192638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.